Alport Syndrome Foundation, Inc. – Trademark Portfolio
Entity Type: 99
Alport Syndrome Foundation, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ALPORT SYNDROME FOUNDATION. The owner is based in Phoenix, AZ.
1608 E. Briarwood Terrace
Phoenix, AZ 850489414
Showing of trademarks Trademarks
Trademark Classifications
Alport Syndrome Foundation, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Alport Syndrome Foundation, Inc. have?
Alport Syndrome Foundation, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Alport Syndrome Foundation, Inc. file in?
Alport Syndrome Foundation, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Alport Syndrome Foundation, Inc.'s most well-known trademarks?
Alport Syndrome Foundation, Inc.'s registered trademark portfolio includes well-known marks such as ALPORT SYNDROME FOUNDATION. These are among 1 currently registered trademark in the portfolio.
What is Alport Syndrome Foundation, Inc.'s trademark registration success rate?
Alport Syndrome Foundation, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.